Actas de congresos
A Clinical Study Of 77 Patients With Mucopolysaccharidosis Type Ii
Acta Paediatrica, International Journal Of Paediatrics. , v. 96, n. SUPPL. 455, p. 63 - 70, 2007.
De Michelena M.
Aim: This study aims to assess the clinical features of 77 South American patients (73 Brazilian) with mucopolysaccharidosis type II (MPS II). Methods: Details of the patients and their disease manifestations were obtained from a review of medical records, interviews with the patients and/or their families, and physical examination of the patients. Results: Mean birth weight was 3360 g, median age at onset of symptoms was 18 months and median age at diagnosis was 6 years. For the whole sample (median age, 8.2 years; range, 2.8-53.0 years), neurological degeneration, typical pebbly skin lesions, seizures and extensive dermal melanocytosis were found in 23.3, 13.0, 13.0 and 1.3% of the cases, respectively. The most frequently reported echocardiogram abnormality was mitral valve regurgitation. Refraction errors were the most common ophthalmological manifestation. The following characteristics were found to be associated with the severe form of MPS II: earlier age at biochemical diagnosis, higher levels of urinary glycosaminoglycans, language development delay, behavioural disturbances, poor school performance and mental retardation. Conclusion: Our results suggest that there is a considerable delay between the onset of signs and symptoms and the diagnosis of MPS II in Brazil (and probably in South America as well), and that many complications of this disease are underdiagnosed and undertreated. Therefore, the implementation of programmes aiming to increase the awareness of the disease, the availability of biochemical diagnostic tests and the provision of better support to affected patients is urgently needed. © 2007 The Author(s).96SUPPL. 4556370Neufeld, E., Muenzer, J., The mucopolysaccharidoses (2001) The metabolic and molecular bases of inherited disease, pp. 3421-3452. , Schriver CR, Beaudet AL, Sly WS, Valle D, editors, New York: McGraw-Hill;Applegarth, D.A., Toone, J.R., Lowry, R.B., Incidence of inborn errors of metabolism in British Columbia, 1969-1996 (2000) Pediatrics, 105, pp. e10Young, I.D., Harper, P.S., Incidence of Hunter's syndrome (1982) Hum Genet, 60, pp. 391-392Machill, G., Barbujani, G., Danieli, G.A., Herrmann, F.H., Segregation and sporadic cases in families with Hunter's syndrome (1991) J Med Genet, 28, pp. 398-401Nelson, J., Incidence of the mucopolysaccharidoses in Northern Ireland (1997) Hum Genet, 101, pp. 355-358Poorthuis, B.J., Wevers, R.A., Kleijer, W.J., Groener, J.E., de Jong, J.G., van Weely, S., The frequency of lysosomal storage diseases in The Netherlands (1999) Hum Genet, 105, pp. 151-156Meikle, P.J., Hopwood, J.J., Clague, A.E., Carey, W.F., Prevalence of lysosomal storage disorders (1999) JAMA, 281, pp. 249-254Nelson, J., Crowhurst, J., Carey, B., Greed, L., Incidence of the mucopolysaccharidoses in Western Australia (2003) Am J Med Genet A, 123, pp. 310-313Baehner, F., Schmiedeskamp, C., Krummenauer, F., Miebach, E., Bajbouj, M., Whybra, C., Cumulative incidence rates of the mucopolysaccharidoses in Germany (2005) J Inherit Metab Dis, 28, pp. 1011-1017Schaap, T., Bach, G., Incidence of mucopolysaccharidoses in Israel: Is Hunter disease a "Jewish disease"? (1980) Hum Genet, 56, pp. 221-223Young, I.D., Harper, P.S., Archer, I.M., Newcombe, R.G., A clinical and genetic study of Hunter's syndrome. 1. Heterogeneity (1982) J Med Genet, 19, pp. 401-407Young, I.D., Harper, P.S., Newcombe, R.G., Archer, I.M., A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms (1982) J Med Genet, 19, pp. 408-411Young, I.D., Harper, P.S., Mild form of Hunter's syndrome: Clinical delineation based on 31 cases (1982) Arch Dis Child, 57, pp. 828-836Young, I.D., Harper, P.S., The natural history of the severe form of Hunter's syndrome: A study based on 52 cases (1983) Dev Med Child Neurol, 25, pp. 481-489Muenzer, J., Wraith, J.E., Beck, M., Giugliani, R., Harmatz, P., Eng, C.M., A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) (2006) Genet Med, 8, pp. 465-473Hamill, P.V., Drizd, T.A., Johnson, C.L., Reed, R.B., Roche, A.F., Moore, W.M., Physical growth: National Center for Health Statistics percentiles (1979) Am J Clin Nutr, 32, pp. 607-629Nellhaus, G., Head circumference from birth to eighteen years. Practical composite international and interracial graphs (1968) Pediatrics, 41, pp. 106-114Nóbrega, F.J., Antropometria, patologias e malformações congênitas do recém-nascido brasileiro e estudos de associação com algumas variáveis maternas (1985) J Pediatr (Rio J), 59, pp. S10-S27Stevenson, R.E., Howell, R.R., McKusick, V.A., Suskind, R., Hanson, J.W., Elliott, D.E., The iduronidase-deficient mucopolysaccharidoses: Clinical and roentgenorgraphic features (1976) Pediatrics, 57, pp. 111-122Carter, C.O., Genetics of common single malformations (1976) Br Med Bull, 32, pp. 21-26Wippermann, C.F., Beck, M., Schranz, D., Huth, R., Michel-Behnke, I., Jüngst, B.K., Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses (1995) Eur J Pediatr, 154, pp. 98-101Mohan, U.R., Hay, A.A., Cleary, M.A., Wraith, J.E., Patel, R.G., Cardiovascular changes in children with mucopolysaccharide disorders (2002) Acta Paediatr, 91, pp. 799-804Hanson, M., Lupski, J.R., Hicks, J., Metry, D., Association of dermal melanocytosis with lysosomal storage disease: Clinical features and hypotheses regarding pathogenesis (2003) Arch Dermatol, 139, pp. 916-920Sapadin, A.N., Friedman, I.S., Extensive Mongolian spots associated with Hunter syndrome (1998) J Am Acad Dermatol, 39, pp. 1013-1015Ochiai, T., Ito, K., Okada, T., Chin, M., Shichino, H., Mugishima, H., Significance of extensive Mongolian spots in Hunter's syndrome (2003) Br J Dermatol, 148, pp. 1173-1178Muenzer, J., Mucopolysaccharidoses (1986) Adv Pediatr, 33, pp. 269-302Wraith, J.E., The mucopolysaccharidoses: A clinical review and guide to management (1995) Arch Dis Child, 72, pp. 263-267Froissart, R., Moreira da Silva, I., Guffon, N., Bozon, D., Maire, I., Mucopolysaccharidosis type II - genotype/phenotype aspects (2002) Acta Paediatr, 91 (SUPPL. 439), pp. 82-87Parkinson, E.J., Muller, V., Hopwood, J.J., Brooks, D.A., Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients (2004) Mol Genet Metab, 81, pp. 58-64Gallegos-Arreola, M.P., Machorro-Lazo, M.V., Flores-Martínez, S.E., Zúniga-González, G.M., Figuera, L.E., González-Noriega, A., Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses (2000) Arch Med Res, 31, pp. 505-510